Three New Funding Opportunities - NIA Impact Collaboratory
February 02, 2021 — The NIA Impact Collaboratory has announced 3 new funding opportunities that will support research and training aimed at increasing the nation's capacity to conduct pragmatic clinical trials of non-pharmacological interventions with healthcare systems to improve the care of people living with AD/ADRD and their care partners.
Penn Frontotemporal Degeneration (FTD) Center’s virtual conference: Fighting for the Future: Education and Support for Familial FTD/ALS
January 28, 2021 — Our colleagues at the Penn Frontotemporal Degeneration (FTD) Center presents: Fighting for the Future: Education and Support for Familial FTD/ALS, a virtual conference on Saturday, February 27, 2021 from 6AM-9AM PT. This live event will address the unique challenges and situations that arise from familial or genetic disease. This event will give families the chance to hear from genetic counselors, neurologists, and social workers on the genetics of FTD and ALS.
Announcing the Spring 2021 Round of the Royalty Research Fund grant program
January 15, 2021 — The Office of Research invites applications to the Spring 2021 round of the Royalty Research Fund (RRF) grant program. The purpose of the RRF is to advance new directions in research. Proposals are due Monday, March 1, by 5:00 PM. Awards will be announced by June 15, 2021.
New Round of Innovation Grants - The Garvey Institute for Brain Health Solutions
January 13, 2021 — For the current round of funding, the Institute is looking for innovative uses of technology that have potential to improve access to behavioral health care. Letters of Interest are due February 26. Learn more at the link.
A New Year’s Message of Thanks to Our Research Participants
January 08, 2021 — The ADRC Clinical Core study team shares thoughts of gratitude and hope for 2021
Monday, Jan 11 ADRC Seminar: Integration of mouse and human studies for biomarker discovery in VCID (Vascular contributions to cognitive impairment and dementia)
January 07, 2021 — We welcome you to attend the next ADRC Seminar on Monday, January 11 at 12pm - 1pm. Presenter: Donna M. Wilcock, PhD, Assistant Dean of Biomedicine/ Associate Director, Sanders-Brown Center on Aging/ Robert P. and Mildred A. Moores Endowed Chair in Alzheimer’s Disease/ Professor, Department of Physiology, University of Kentucky College of Medicine.
Watch: Overview of the U19 Human AD Center of the Allen Institute for Brain Science, UW, and Kaiser Permanente Research Institute
December 17, 2020 — The Human AD Center: A platform for cell type-level transcriptomic, epigenomic and spatial interrogation of early selective vulnerability in Alzheimer's disease. Speakers: C. Dirk Keene, MD, PhD / Ed Lein, PhD. Host: UW Neurological Surgery Education Series
Upcoming: ADRC Seminar Series December 14th, 12 pm - 1pm
December 01, 2020 — Join UCSF's James Rini, MD, MPH for the December 14th ADRC Seminar Series presentation: "VR. Neurology or: How I Learned to Stop Worrying and Love Teleneurology." He will speak on the topic of immersive virtual reality diagnostic tools to improve screening, clinical management, and research of neurodegenerative conditions. More info at the link.
Announcing the UW ADRC’s 35th Anniversary Edition of Dimensions Magazine
November 30, 2020 — This special project explores the foundation built by the early researchers and team members of our Center and the fruitful avenues of current research and community work that grow from it today. View the project.
Learn about the IMPACT-AD Informational Webinar
November 19, 2020 — December 15, 2020, 12-pm PT: The Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD) is a novel multidisciplinary Alzheimer’s Disease and Related Dementias clinical trial training program (www.impact-ad.org). In preparation for this year’s application cycle, IMPACT-AD is hosting a webinar interested in the course to learn more about the training program and to have questions answered by the course co-directors Joshua Grill, PhD and Rema Raman, PhD.